Quantcast

Industry news that matters to you.  Learn more

Archives for July 2014

Bruker Announces Powerful New Mass Spectrometry Systems and Solutions for Life-Science Research, Clinical Research, Biopharma and Applied Markets

At the 62nd ASMS Conference on Mass Spectrometry and Allied Topics recently, Bruker Corporation (NASDAQ:BRKR) announced mass spectrometry-based product introductions for life-science research and proteomics, for clinical research, for pharma/biopharma/CRO customers, as well as for applied and industrial markets. The new systems and solutions are designed to deliver confident analyses with significantly enhanced performance, productivity and versatility.

AB SCIEX Next-Generation Proteomics Platform Transforms Proteomics Research

AB SCIEX, a global leader in life science analytical technologies, recently introduced the TripleTOF® 6600 system with SWATH™ Acquisition 2.0 – the company’s revolutionary solution for quantitative proteomics. This high-resolution, accurate-mass system, combined with the new SWATH™ Acquisition 2.0, brings new power to proteomic data challenges for advanced biomarker discovery and systems biology. As the emphasis in proteomics research shifts from cataloguing to comprehensive quantitation, the AB SCIEX solution is uniquely positioned, enabling the quantification of thousands of proteins across large sample sets with a level of data completeness and quantitative accuracy and precision that have only been achievable by “gold-standard,” targeted MRM in the past.

Bonnie J. Addario Lung Cancer Foundation Joins Lung-MAP, Collaborative Group Multi-drug, Biomarker-driven Clinical Trial for Lung Cancer

The Bonnie J. Addario Lung Cancer Foundation (ALCF) has signed on as a collaborating organization with the Lung Cancer Master Protocol (Lung-MAP) clinical trial, which will use genomic profiling to match patients to one of several different investigational treatments that are designed to target the genomic alterations found to be driving the growth of their cancer. This innovative approach to clinical testing should both improve access to promising drugs for patients and ease the significant recruitment and infrastructure burdens on researchers involved in traditional clinical trials.

Agilent Technologies’ New LC/MS Triple Quadrupole Provides Confident Quantitation and Confirmation for Most Demanding Applications

Agilent Technologies Inc. (NYSE: A) recently introduced a new flagship triple quadrupole mass spectrometer for LC/MS applications requiring the highest sensitivity and robustness. The Agilent 6495 LC/MS Triple Quadrupole system is fully integrated with Agilent’s 1200 series UHPLC systems to deliver turnkey performance. The newest addition to the 6400 LC/MS Triple Quadrupole Series, the 6495 is designed for both routine laboratory analysis and for the most challenging quantitation in life sciences, food and environmental applications.

Ohio State and Moffitt Form World’s Largest Cancer Research Collaboration for Big Data; More Than 100,000 Patients Already Participating

Two of North America’s leading cancer centers, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), recently announced what is likely the largest collaboration of its kind to accelerate discoveries in cancer research.